Delivery Order SPE2DX22D0010-SPE2D824FPL34

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $6.2K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,000.16, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of oxymorphone hydrochloride extended-release tablets, a pain management medication, with a completion date of November 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,570.06 firm-fixed-price delivery order covers the supply of Oxymorphone HCL ER 20 mg tablets. The contract has an ultimate completion date of March 8, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $5,509.62, is for the delivery of oxymorphone hydrochloride extended-release tablets with a 40mg strength. The contract is a firm-fixed-price delivery order with a performance period ending on January 2, 2024. There is no set-aside designation for this award....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,679.80, is a delivery order for the supply of 4567075298 - Oxymorphone HCL ER Tabs 10mg. The contract has a firm fixed price pricing type and a period of performance through January 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,938.49 firm fixed-price delivery order is for the supply of 40mg oxymorphone hydrochloride extended-release tablets, with a completion date of January 24, 2023. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen...
This federal contract award, with ID SPE2DX22D0010|SPE2D823FCF31, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $5,132.36 firm fixed-price delivery order is for the supply of 40mg oxymorphone hydrochloride extended-release tablets, with a completion date of January 3, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,862.76, is for the delivery of oxymorphone hydrochloride extended-release tablets, a prescription pain medication. The contract is a firm-fixed price delivery order with a completion date of July 25, 2024. The award is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. The $6,729.58 Firm Fixed Price Delivery Order is for the supply of 30mg Oxymorphone Hydrochloride Extended Release Tablets, a prescription medication. The award is associated with Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Oxymorphone HCL ER Tabs 40mg to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,566.16 firm fixed price contract has a completion date of June 21, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, with ID SPE2DX22D0010|SPE2D823FDC97, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,340.27 firm-fixed-price delivery order is for the supply of 40mg oxymorphone hydrochloride extended-release tablets, with a period of performance through January 23, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D824FPL34
    Delivery Order

This federal contract award, valued at $6,180.88, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of oxymorphone hydrochloride extended-release tablets, 40mg, with an ultimate completion date of July 29, 2024.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. This specific contract award does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 10:11 AM